RESMED INC (RMD)
Every FINRA and SEC series the site collects for RESMED INC: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on NYSE, classified by the SEC as surgical & medical instruments & apparatus.
13.1M
Short interest
settlement 2026-08-31
8.9
Days to cover
+2.2% vs prior
78.1%
Short share of volume
2026-09-17
9,869
Fails to deliver
settlement 2026-08-31
Thu 29 Oct
Next earnings
estimated; last year 2025-10-30
-$4.1M
Insider flow, 90 days
0 buys, 4 sells
As of 2026-09-17.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in RMD is 13,073,165 shares, down 2,603,451 shares over the last month. Over the last 48 readings it ranged from 7,312,478 shares (15 November 2024) to 15,676,616 shares (31 July 2026). At the reported average volume of 1.5M shares a day that is 8.9 days to cover, elevated.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/rmd" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 13,073,165 | +2.2% | 1,462,283 | 8.94 |
| 2026-08-14 | 12,794,915 | -18.4% | 1,727,103 | 7.41 |
| 2026-07-31 | 15,676,616 | +15.8% | 1,104,429 | 14.19 |
| 2026-07-15 | 13,541,103 | -10.3% | 1,726,912 | 7.84 |
| 2026-06-30 | 15,104,487 | +16.9% | 1,778,242 | 8.49 |
| 2026-06-15 | 12,915,210 | +8.7% | 1,431,442 | 9.02 |
| 2026-05-29 | 11,881,847 | -12.5% | 1,618,671 | 7.34 |
| 2026-05-15 | 13,573,617 | +10.4% | 1,612,973 | 8.42 |
| 2026-04-30 | 12,298,239 | +7.0% | 1,195,806 | 10.28 |
| 2026-04-15 | 11,494,456 | -3.3% | 906,361 | 12.68 |
| 2026-03-31 | 11,889,620 | +0.4% | 1,067,023 | 11.14 |
| 2026-03-13 | 11,845,253 | +0.1% | 1,048,993 | 11.29 |
| 2026-02-27 | 11,837,993 | +17.2% | 965,467 | 12.26 |
| 2026-02-13 | 10,098,338 | -9.2% | 1,462,658 | 6.90 |
| 2026-01-30 | 11,124,518 | -2.7% | 1,173,742 | 9.48 |
| 2026-01-15 | 11,433,978 | -2.0% | 870,817 | 13.13 |
| 2025-12-31 | 11,672,492 | +10.6% | 945,555 | 12.34 |
| 2025-12-15 | 10,557,741 | +1.4% | 889,744 | 11.87 |
| 2025-11-28 | 10,416,904 | -2.2% | 937,247 | 11.11 |
| 2025-11-14 | 10,647,780 | +9.9% | 1,386,837 | 7.68 |
| 2025-10-31 | 9,690,007 | +8.1% | 1,282,242 | 7.56 |
| 2025-10-15 | 8,964,374 | +1.8% | 833,890 | 10.75 |
| 2025-09-30 | 8,806,208 | +1.8% | 870,896 | 10.11 |
| 2025-09-15 | 8,649,291 | +1.6% | 1,028,349 | 8.41 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 17 September 2026, the short share of RMD volume is 78.1%, up 12.1 points over the last five sessions. Over the last 52 readings it ranged from 53.0% (28 July 2026) to 89.0% (8 September 2026). The latest reading is in line with the 30-session average of 77.9%, on 463K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-17 | 362K | 463K | 78.1% | 23 |
| 2026-09-16 | 414K | 479K | 86.5% | 0 |
| 2026-09-15 | 550K | 643K | 85.5% | 0 |
| 2026-09-14 | 278K | 333K | 83.5% | 24 |
| 2026-09-11 | 239K | 336K | 71.2% | 9 |
| 2026-09-10 | 228K | 345K | 66.1% | 61 |
| 2026-09-09 | 345K | 414K | 83.5% | 12 |
| 2026-09-08 | 425K | 478K | 89.0% | 25 |
| 2026-09-04 | 283K | 320K | 88.4% | 0 |
| 2026-09-03 | 208K | 304K | 68.5% | 0 |
| 2026-09-02 | 339K | 441K | 76.7% | 18 |
| 2026-09-01 | 292K | 382K | 76.6% | 0 |
| 2026-08-31 | 386K | 463K | 83.4% | 39 |
| 2026-08-28 | 397K | 473K | 83.8% | 1 |
| 2026-08-27 | 429K | 539K | 79.6% | 148 |
| 2026-08-26 | 407K | 483K | 84.1% | 71 |
| 2026-08-25 | 540K | 650K | 83.1% | 0 |
| 2026-08-24 | 282K | 379K | 74.4% | 6 |
| 2026-08-21 | 284K | 378K | 75.1% | 20 |
| 2026-08-20 | 322K | 410K | 78.6% | 81 |
| 2026-08-19 | 316K | 422K | 74.8% | 37 |
| 2026-08-18 | 375K | 452K | 83.0% | 93 |
| 2026-08-17 | 452K | 576K | 78.6% | 6,560 |
| 2026-08-14 | 245K | 404K | 60.7% | 58 |
| 2026-08-13 | 335K | 418K | 80.2% | 0 |
| 2026-08-12 | 397K | 515K | 77.0% | 943 |
| 2026-08-11 | 333K | 488K | 68.4% | 35 |
| 2026-08-10 | 469K | 639K | 73.4% | 52 |
| 2026-08-07 | 1.3M | 1.7M | 78.1% | 66 |
| 2026-08-06 | 553K | 830K | 66.6% | 0 |
Fails to deliver
SEC, by settlement date. JSONAs of 31 August 2026, the fails-to-deliver balance in RMD is 9,869 shares, up 9,800 shares over the last settlement date. Over the last 52 readings it ranged from 1 share (3 March 2026) to 56,021 shares (22 April 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-31 | 9,869 | $240.33 | $2.4M |
| 2026-08-27 | 69 | $235.69 | $16K |
| 2026-08-24 | 200 | $231.52 | $46K |
| 2026-08-20 | 298 | $230.65 | $69K |
| 2026-08-18 | 38 | $220.37 | $8K |
| 2026-08-12 | 22 | $224.84 | $5K |
| 2026-08-11 | 70 | $220.05 | $15K |
| 2026-08-10 | 21,011 | $211.94 | $4.5M |
| 2026-07-22 | 43,590 | $195.80 | $8.5M |
| 2026-07-21 | 44,905 | $198.61 | $8.9M |
| 2026-07-10 | 60 | $208.45 | $13K |
| 2026-07-09 | 207 | $205.84 | $43K |
| 2026-07-08 | 274 | $219.75 | $60K |
| 2026-07-07 | 210 | $218.40 | $46K |
| 2026-07-06 | 2,170 | $209.63 | $455K |
| 2026-07-01 | 5,407 | $194.88 | $1.1M |
| 2026-06-29 | 8,731 | $200.29 | $1.7M |
| 2026-06-25 | 6,855 | $196.50 | $1.3M |
| 2026-06-22 | 47,619 | $188.63 | $9.0M |
| 2026-06-15 | 166 | $194.78 | $32K |
| 2026-06-04 | 245 | $186.46 | $46K |
| 2026-05-28 | 73 | $206.10 | $15K |
| 2026-05-13 | 9,948 | $203.79 | $2.0M |
| 2026-05-08 | 2,008 | $206.89 | $415K |
| 2026-05-06 | 417 | $207.88 | $87K |
| 2026-05-04 | 4,920 | $205.02 | $1.0M |
| 2026-05-01 | 17,589 | $213.81 | $3.8M |
| 2026-04-27 | 846 | $219.85 | $186K |
| 2026-04-24 | 14,260 | $219.51 | $3.1M |
| 2026-04-22 | 56,021 | $221.22 | $12.4M |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at RMD reported 4 open-market sells worth $4.1M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: FARRELL PETER C on 2026-09-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | FARRELL PETER C | n/a | Sell | 970 | $234.73 | $228K | 52K |
| 2026-08-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $205.69 | $1.0M | 466K |
| 2026-08-07 | Farrell Michael J. | Chairman and CEO | Option exercise | 5K | $146.34 | $730K | 471K |
| 2026-08-05 | FARRELL PETER C | n/a | Sell | 8K | $225.00 | $1.8M | 53K |
| 2026-07-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $218.55 | $1.1M | 466K |
| 2026-07-07 | Farrell Michael J. | Chairman and CEO | Option exercise | 5K | $146.34 | $730K | 471K |
| 2026-06-08 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $193.96 | $968K | 466K |
| 2026-06-08 | Farrell Michael J. | Chairman and CEO | Option exercise | 5K | $146.34 | $730K | 471K |
| 2026-06-01 | Rider Michael J | Global General Counsel | Tax withholding | 269 | $190.57 | $51K | 9K |
| 2026-06-01 | Rider Michael J | Global General Counsel | Tax withholding | 269 | $190.57 | $51K | 9K |
| 2026-05-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $207.82 | $1.0M | 466K |
| 2026-05-07 | Farrell Michael J. | Chairman and CEO | Option exercise | 5K | $146.34 | $730K | 471K |
| 2026-04-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $225.50 | $1.1M | 466K |
| 2026-04-07 | Farrell Michael J. | Chairman and CEO | Option exercise | 5K | $146.34 | $730K | 471K |
| 2026-04-01 | FARRELL PETER C | n/a | Sell | 2K | $225.00 | $450K | 61K |
| 2026-04-01 | Sandercock Brett | Chief Financial Officer | Sell | 1K | $224.31 | $224K | 83K |
| 2026-03-09 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $251.03 | $1.3M | 466K |
| 2026-03-09 | Farrell Michael J. | Chairman and CEO | Option exercise | 5K | $146.34 | $730K | 471K |
| 2026-03-04 | FARRELL PETER C | n/a | Sell | 2K | $260.22 | $520K | 63K |
| 2026-03-02 | Sandercock Brett | Chief Financial Officer | Sell | 1K | $254.30 | $254K | 84K |
| 2026-02-09 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $273.78 | $1.4M | 466K |
| 2026-02-09 | Farrell Michael J. | Chairman and CEO | Option exercise | 5K | $146.34 | $730K | 471K |
| 2026-02-04 | Rider Michael J | Global General Counsel | Sell | 50 | $260.00 | $13K | 10K |
| 2026-02-04 | FARRELL PETER C | n/a | Sell | 2K | $251.31 | $503K | 65K |
| 2026-02-02 | Sandercock Brett | Chief Financial Officer | Sell | 1K | $257.03 | $257K | 85K |
| 2026-01-07 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $248.46 | $1.2M | 466K |
| 2026-01-07 | Farrell Michael J. | Chairman and CEO | Option exercise | 5K | $146.34 | $730K | 471K |
| 2026-01-07 | FARRELL PETER C | n/a | Sell | 2K | $248.83 | $498K | 67K |
| 2026-01-02 | Sandercock Brett | Chief Financial Officer | Sell | 1K | $241.75 | $242K | 86K |
| 2026-01-02 | Rider Michael J | Global General Counsel | Sell | 50 | $241.75 | $12K | 10K |
| 2025-12-08 | Farrell Michael J. | Chairman and CEO | Sell | 5K | $251.41 | $1.3M | 466K |
| 2025-12-08 | Farrell Michael J. | Chairman and CEO | Option exercise | 5K | $146.34 | $730K | 471K |
| 2025-12-03 | FARRELL PETER C | n/a | Sell | 2K | $251.47 | $503K | 69K |
| 2025-12-01 | Rider Michael J | Global General Counsel | Sell | 50 | $244.16 | $12K | 10K |
| 2025-12-01 | Sandercock Brett | Chief Financial Officer | Sell | 1K | $244.16 | $244K | 87K |
| 2025-11-25 | De Witte Jan | n/a | Sell | 2K | $255.00 | $524K | 4K |
| 2025-11-20 | Tan Desney | n/a | Grant | 1K | $0.00 | $0 | 6K |
| 2025-11-20 | TAYLOR RONALD R | n/a | Grant | 1K | $0.00 | $0 | 25K |
| 2025-11-20 | Sandercock Brett | Chief Financial Officer | Grant | 3K | $0.00 | $0 | 88K |
| 2025-11-20 | Mowad-Nassar Nicole | n/a | Grant | 536 | $0.00 | $0 | 777 |
| 2025-11-20 | Leong Justin | Chief Product Officer | Grant | 2K | $0.00 | $0 | 29K |
| 2025-11-20 | Hernandez John | n/a | Grant | 1K | $0.00 | $0 | 5K |
| 2025-11-20 | Gill Harjit | n/a | Grant | 1K | $0.00 | $0 | 11K |
| 2025-11-20 | Farrell Michael J. | Chairman and CEO | Tax withholding | 7K | $0.00 | $0 | 466K |
| 2025-11-20 | Farrell Michael J. | Chairman and CEO | Grant | 14K | $0.00 | $0 | 474K |
| 2025-11-20 | FARRELL PETER C | n/a | Grant | 536 | $0.00 | $0 | 71K |
| 2025-11-20 | Drexler Karen | n/a | Grant | 1K | $0.00 | $0 | 11K |
| 2025-11-20 | DelOrefice Christopher | n/a | Grant | 1K | $0.00 | $0 | 2K |
| 2025-11-20 | De Witte Jan | n/a | Grant | 1K | $0.00 | $0 | 6K |
| 2025-11-20 | Burt Carol | n/a | Grant | 1K | $0.00 | $0 | 2K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON33 Form 144 notices on file for RMD worth $25.3M at the prices reported; 3 in the last 90 days worth $3.3M. Latest: Farrell Michael J. filed on 2026-09-08 to sell 4,991 shares ($1.1M) from 2026-09-08.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-08 | Farrell Michael J.Officer, Director | 5K | $1.1M | 0.003% | 2026-09-08 | Fidelity Brokerage Services LLC |
| 2026-08-07 | Farrell Michael J.Officer, Director | 5K | $1.0M | 0.003% | 2026-08-07 | Fidelity Brokerage Services LLC |
| 2026-07-07 | Farrell Michael J.Officer, Director | 5K | $1.1M | 0.003% | 2026-07-07 | Fidelity Brokerage Services LLC |
| 2026-06-08 | Farrell Michael J.Officer, Director | 5K | $968K | 0.003% | 2026-06-08 | Fidelity Brokerage Services LLC |
| 2026-05-27 | Sandercock BrettFormer Officer | 8K | $1.7M | 0.006% | 2026-05-27 | Fidelity Brokerage Services LLC |
| 2026-05-07 | Farrell Michael J.Officer, Director | 5K | $1.0M | 0.003% | 2026-05-07 | Fidelity Brokerage Services LLC |
| 2026-04-07 | Farrell Michael J.Officer, Director | 5K | $1.1M | 0.003% | 2026-04-07 | Fidelity Brokerage Services LLC |
| 2026-04-01 | Sandercock BrettOfficer | 1K | $224K | 0.001% | 2026-04-01 | Fidelity Brokerage Services LLC |
| 2026-04-01 | Peter C FarrellDirector | 2K | $450K | 0.004% | 2026-04-01 | Merrill Lynch |
| 2026-03-09 | Farrell Michael J.Officer, Director | 5K | $1.2M | 0.003% | 2026-03-09 | Fidelity Brokerage Services LLC |
| 2026-03-04 | Peter C FarrellDirector | 2K | $520K | 0.004% | 2026-03-04 | Merrill Lynch |
| 2026-03-02 | Sandercock BrettOfficer | 1K | $254K | 0.001% | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2026-02-09 | Farrell Michael J.Officer, Director | 5K | $1.4M | 0.003% | 2026-02-09 | Fidelity Brokerage Services LLC |
| 2026-02-04 | Rider Michael JOfficer | 50 | $13K | 0.000% | 2026-02-04 | Fidelity Brokerage Services LLC |
| 2026-02-04 | Peter C FarrellDirector | 2K | $503K | 0.004% | 2026-02-04 | Merrill Lynch |
| 2026-02-02 | Sandercock BrettOfficer | 1K | $257K | 0.001% | 2026-02-02 | Fidelity Brokerage Services LLC |
| 2026-01-07 | Farrell Michael J.Officer, Director | 5K | $1.2M | 0.003% | 2026-01-07 | Fidelity Brokerage Services LLC |
| 2026-01-07 | Peter C FarrellDirector | 2K | $498K | 0.004% | 2026-01-07 | Merrill Lynch |
| 2026-01-02 | Sandercock BrettOfficer | 1K | $242K | 0.001% | 2026-01-02 | Fidelity Brokerage Services LLC |
| 2026-01-02 | Rider Michael JOfficer | 50 | $12K | 0.000% | 2026-01-02 | Fidelity Brokerage Services LLC |
| 2025-12-08 | Farrell Michael J.Officer, Director | 5K | $1.3M | 0.003% | 2025-12-08 | Fidelity Brokerage Services LLC |
| 2025-12-03 | Peter C FarrellDirector | 2K | $503K | 0.004% | 2025-12-03 | Merrill Lynch |
| 2025-12-01 | Sandercock BrettOfficer | 1K | $244K | 0.001% | 2025-12-01 | Fidelity Brokerage Services LLC |
| 2025-12-01 | Rider Michael JOfficer | 50 | $12K | 0.000% | 2025-12-01 | Fidelity Brokerage Services LLC |
| 2025-11-25 | De Witte JanDirector | 2K | $524K | 0.001% | 2025-11-25 | Fidelity Brokerage Services LLC |
| 2025-11-12 | Peter C FarrellDirector | 2K | $504K | 0.004% | 2025-11-12 | Merrill Lynch |
| 2025-11-12 | De Witte JanDirector | 487 | $122K | 0.000% | 2025-11-11 | Fidelity Brokerage Services LLC |
| 2025-11-07 | Farrell Michael J.Officer, Director | 8K | $2.0M | 0.005% | 2025-11-07 | Fidelity Brokerage Services LLC |
| 2025-11-03 | Sandercock BrettOfficer | 3K | $743K | 0.002% | 2025-11-03 | Fidelity Brokerage Services LLC |
| 2025-10-07 | Ghoshal KaushikFormer Officer | 5K | $1.4M | 0.003% | 2025-10-07 | Fidelity Brokerage Services LLC |
| 2025-10-07 | Farrell Michael J.Officer, Director | 8K | $2.3M | 0.005% | 2025-10-07 | Fidelity Brokerage Services LLC |
| 2025-10-01 | Rider Michael JOfficer | 100 | $27K | 0.000% | 2025-10-01 | Fidelity Brokerage Services LLC |
| 2025-10-01 | Sandercock BrettOfficer | 3K | $823K | 0.002% | 2025-10-01 | Fidelity Brokerage Services LLC |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON4 holders above 5% have filed on RMD, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 8.2% of the class (11,961,706 shares), filed 2026-04-29 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-07 | 13G | AustralianSuper Pty Ltdnon-US institution | 8.3M | 5.7% | 2026-06-30 |
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 12.0M | 8.2% | 2026-03-31 |
| 2026-04-29 | 13G | Vanguard Portfolio Managementinvestment adviser | 7.9M | 5.4% | 2026-03-31 |
| 2026-03-27 | 13G/Ano. 14 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2025-10-30 | 13G/Ano. 13 | The Vanguard Groupinvestment adviser | 20.0M | 13.7% | 2025-09-30 |
13F holders
Tracked managers holding RMD at their latest 13F. JSON9 of the 30 tracked managers held RMD at their latest 13F, $447.5M in total at quarter-end prices. AQR Capital Management is the largest at $177.1M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 4 added shares and 4 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| AQR Capital Management | 2026-06-30 | 911K | $177.1M | 0.06% | +561K |
| Citadel Advisors | 2026-06-30 | 610K | $119.0M | 0.01% | +190K |
| Two Sigma Investments | 2026-06-30 | 411K | $80.1M | 0.06% | +99K |
| Millennium Management | 2026-06-30 | 237K | $46.2M | 0.02% | -65K |
| Bridgewater Associates | 2026-06-30 | 67K | $13.1M | 0.05% | +28K |
| Fisher Asset Management | 2026-06-30 | 53K | $10.2M | 0.00% | -2K |
| D. E. Shaw & Co. | 2026-06-30 | 6K | $1.2M | 0.00% | -5K |
| Renaissance Technologies | 2026-06-30 | 2K | $316K | 0.00% | -303K |
| Point72 Asset Management | 2026-06-30 | 1K | $234K | 0.00% | 0 |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q4 2026 (quarter ended 2026-06-30) RESMED INC reported revenue of $1.46B, up 8.6% from the same quarter a year earlier, and net income of $383.4M. In FY 2026 it generated $1.81B of operating cash flow and spent $700.0M on buybacks and $349.7M on dividends. As of 2026-06-30, cash was $1.47B against $399.4M of debt.
- Cash
- $1.47B
- Debt
- $399.4M
- Equity
- $6.59B
- Total assets
- $8.97B
- Shares outstanding
- 144,252,306
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q4 2026derived | 2026-06-30 | $1.46B | $383.4M | 26.2% | n/a |
| Q1 2026 | 2026-03-31 | $1.43B | $398.7M | 27.9% | 2.74 |
| Q4 2025 | 2025-12-31 | $1.42B | $392.6M | 27.6% | 2.68 |
| Q3 2025 | 2025-09-30 | $1.34B | $348.5M | 26.1% | 2.37 |
| Q4 2025derived | 2025-06-30 | $1.35B | $379.7M | 28.2% | n/a |
| Q1 2025 | 2025-03-31 | $1.29B | $365.0M | 28.3% | 2.48 |
| Q4 2024 | 2024-12-31 | $1.28B | $344.6M | 26.9% | 2.34 |
| Q3 2024 | 2024-09-30 | $1.22B | $311.4M | 25.4% | 2.11 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2026 | 2026-06-30 | $5.65B | $1.52B | $1.81B | $156.3M | $700.0M | $349.7M |
| FY 2025 | 2025-06-30 | $5.15B | $1.40B | $1.75B | $89.9M | $300.0M | $310.9M |
| FY 2024 | 2024-06-30 | $4.69B | $1.02B | $1.40B | $99.5M | $150.0M | $282.3M |
| FY 2023 | 2023-06-30 | $4.22B | $897.6M | $693.3M | $119.7M | $0 | $258.3M |
| FY 2022 | 2022-06-30 | $3.58B | $779.4M | $351.1M | $134.8M | $0 | $245.3M |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-10 from the cover page.
What this page is
RESMED INC in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows RESMED INC (RMD), SEC CIK 943819, listed on NYSE, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-31.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-09-08.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-08-07.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-08-06.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-09-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 943819Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
- BSXBOSTON SCIENTIFIC CORP
- TNDMTANDEM DIABETES CARE INC
- DXCMDEXCOM INC
- PENPenumbra Inc
- SIBNSI-BONE, Inc.
- MMM3M CO
- LMATLEMAITRE VASCULAR INC
- INSPInspire Medical Systems, Inc.
- NVCRNovoCure Ltd
- SYKSTRYKER CORP
- GKOSGLAUKOS Corp
- IRTCiRhythm Holdings, Inc.
- ICUIICU MEDICAL INC/DE
- ATECAlphatec Holdings, Inc.
- AORTARTIVION, INC.
- PODDINSULET CORP
- BDXBECTON DICKINSON & CO
- IRMDIRADIMED CORP
- ATRCAtriCure, Inc.
- UFPTUFP TECHNOLOGIES INC
- LUNGPulmonx Corp
- MMSIMERIT MEDICAL SYSTEMS INC
- ANGOANGIODYNAMICS INC
- OFIXOrthofix Medical Inc.
Datasets
Frequently Asked Questions
How much of RMD is sold short?
What is RMD's daily short volume?
Does RMD have fails to deliver?
Are RMD insiders buying or selling?
Have RMD insiders filed to sell?
Who owns more than 5% of RMD?
What did RMD report last quarter?
Which funds hold RMD?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.